We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

BICO Group AB (BICO) NPV

Sell:32.14 SEK Buy:32.42 SEK Change: 0.16 SEK (0.49%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Sell:32.14 SEK
Buy:32.42 SEK
Change: 0.16 SEK (0.49%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Sell:32.14 SEK
Buy:32.42 SEK
Change: 0.16 SEK (0.49%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.

Contact details

Address:
Langfilsgatan 9
GOETEBORG
412 77
Sweden
Telephone:
+46 () 20101000
Website:
https://bico.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
BICO
ISIN:
SE0013647385
Market cap:
2.24 billion SEK
Shares in issue:
70.57 million
Sector:
Life Sciences Tools & Services
Exchange:
Stockholm Stock Exchange
Country:
Sweden
Currency:
Swedish Krona
Indices:
n/a

Key personnel

  • Maria Forss
    President, Chief Executive Officer
  • Jacob Thordenberg
    Chief Financial Officer
  • Marius Balger
    Chief Operating Officer
  • Lotta Bus
    Senior Vice President, General Counsel
  • Anders Fogelberg
    Chief Commercial Officer
  • Catharina Nordlund
    Global Head of Human Resources

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.